Cancer Therapy News and Research

RSS

Relative of the celebrated COX-2 inhibitor celecoxib is tough tumor fighter

A close structural relative of the celebrated COX-2 inhibitor celecoxib (brand name: Celebrex) is a potent tumor fighter, able to wipe out tumor cells that are resistant to conventional chemotherapies, according to an interdisciplinary team of researchers from the University of Southern California.

29 Aug 2005

New strategy to turn off the function of a special group of T cells to suppress immune response to tumors

A special stretch of genetic material may turn off the immune suppression that stymies attempts to fight cancer with a vaccine, said researchers at Baylor College of Medicine (BCM) at Houston.

26 Aug 2005

Teen cancer patients need specially designed wards

According to an National Health Advisory Body in the UK, most children and teenagers with cancer are treated on adult or paediatric wards.

25 Aug 2005

Young breast cancer sufferers need more fertility advice before treatment

According to new research led by the University of New South Wales (UNSW), Australia, 25% of young breast cancer sufferers say that there was no discussion of fertility issues at the time of diagnosis, despite the possibility of infertility after treatment.

22 Aug 2005

Discovery of signaling component that influences spread of breast cancer cells

Researchers at the Virginia Commonwealth University Massey Cancer Center have found a new signaling component that influences movement of human breast cancer cells toward epidermal growth factor.

22 Aug 2005

A cell's energy level is critical to its survival

In an ongoing effort to fight disease by manipulating energy regulation of cells, a collaborative study led by Dartmouth Medical School (DMS) has demonstrated that cells lacking a tumor-suppressing kinase called LKB1 can still maintain healthy energy levels when they become stressed.

22 Aug 2005

Many phase I trials for new cancer fighting drugs never get reported in peer-reviewed journals

A new study finds many phase I trials for new cancer fighting drugs never get reported in peer-reviewed journals, and says investigators should be committed not just to finding novel compounds, but also to make sure final results of their studies be disseminated to the medical community.

22 Aug 2005

Adalimumab and methotrexate is about five times more effective than methotrexate alone for rheumatoid arthritis

For people with long-standing rheumatoid arthritis, combined treatment with the new "biologic" drug adalimumab and methotrexate is about five times more effective than methotrexate alone, according to a new systematic review of studies.

15 Aug 2005

Researchers discover that tumors secrete fatty acids which inhibit the cytotoxic T lymphocytes' ability to kill tumor cells

Researchers have discovered that tumors release fatty acids that interfere with the cells that are trying to kill them. Consequently, strategies that reduce the amount of fatty acids surrounding the tumors may give a boost to anti-cancer therapeutics.

11 Aug 2005

FDA approval sought for Pfizer's new cancer drug

Drug company Pfizer has announced it has submitted a New Drug Application (NDA) for its cancer drug Sutent, to the U.S. Food and Drug Administration (FDA).

11 Aug 2005

Testing for the activity of certain genes can predict response to chemotherapy for breast cancer

Breast cancer patients could find out whether they will respond positively to chemotherapy treatment by testing for the activity of certain genes.

9 Aug 2005

Strategic analyses of European In-Vitro cancer diagnostics market - Cancer research yields promising results

Every year, nearly one in four Europeans - a total of almost one million people - dies from cancer, giving Europe the dubious distinction of having amongst the highest cancer-related mortality rates in the world. Even as cancer remains a difficult disease to diagnose, often resulting in either poor diagnosis or misdiagnosis, the number of new cancer cases is set to double by 2020.

2 Aug 2005

Monash University software helps tackle cancer and aircraft design

A powerful software tool designed by academics at Monash University is being used in the UK to help develop cancer treatments and improve aircraft engine design.

2 Aug 2005

Cancer survivors initiate diet, exercise, and other beneficial lifestyle changes following a cancer diagnosis

An analysis of more than 100 studies of cancer survivors shows that many survivors initiate diet, exercise, and other beneficial lifestyle changes following a cancer diagnosis, but that those who are male, older, and less educated are less likely to adopt such changes. The term "cancer survivor" refers to a person who has been diagnosed with cancer.

25 Jul 2005

Government in Ontario will pay for three new cancer drugs

Canadian Health Minister George Smitherman has announced that the government will add three new and expensive cancer-fighting drugs to the list of medications it funds.

25 Jul 2005

Potential new target for stomach cancer therapy

It started several years ago with the observation that a large group of seemingly unconnected genes were behaving differently in patients with stomach cancer.

24 Jul 2005

Many testicular cancer patients are able to father children

According to Dr Robert Huddart of the Institute of Cancer Research in London, the vast majority of men, after testicular cancer treatment, can go on and have a family as normal.

23 Jul 2005

Provectus to begin clinical trials of new cancer treatment, PV-10

Provectus Pharmaceuticals announced today that it has obtained final clearance to begin the first Phase 1 clinical trial of PV-10, the Company's lead cancer treatment.

21 Jul 2005

Role of IL-24 in regulating the immune system

Researchers at Introgen Therapeutics and their collaborators at The University of Texas M. D. Anderson Cancer Center have published new findings on the role of IL-24 in regulating the immune system in the current online issue of the Journal of Leukocyte Biology.

21 Jul 2005

Fertility boost for testicular cancer patients

The vast majority of men who try to have a family, following treatment for testicular cancer, are able to father children - according to a report published today in the British Journal of Cancer.

21 Jul 2005

Cancer Therapy News and Research

Relative of the celebrated COX-2 inhibitor celecoxib is tough tumor fighter

New strategy to turn off the function of a special group of T cells to suppress immune response to tumors

Teen cancer patients need specially designed wards

Young breast cancer sufferers need more fertility advice before treatment

Discovery of signaling component that influences spread of breast cancer cells

A cell's energy level is critical to its survival

Many phase I trials for new cancer fighting drugs never get reported in peer-reviewed journals

Adalimumab and methotrexate is about five times more effective than methotrexate alone for rheumatoid arthritis

Researchers discover that tumors secrete fatty acids which inhibit the cytotoxic T lymphocytes' ability to kill tumor cells

FDA approval sought for Pfizer's new cancer drug

Testing for the activity of certain genes can predict response to chemotherapy for breast cancer

Strategic analyses of European In-Vitro cancer diagnostics market - Cancer research yields promising results

Monash University software helps tackle cancer and aircraft design

Cancer survivors initiate diet, exercise, and other beneficial lifestyle changes following a cancer diagnosis

Government in Ontario will pay for three new cancer drugs

Potential new target for stomach cancer therapy

Many testicular cancer patients are able to father children

Provectus to begin clinical trials of new cancer treatment, PV-10

Role of IL-24 in regulating the immune system

Fertility boost for testicular cancer patients

Your guide to microplate readers for cancer research eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News